Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
2024

Dupilumab for Eosinophilic Gastritis and Severe Asthma

Sample size: 1 publication Evidence: low

Author Information

Author(s): Takeshige Tomohito, Koyama Ryo, Motomura Hiroaki, Okajima Akifumi, Nishioki Toshihiko, Watanabe Junko, Yae Toshifumi, Kido Kenji, Takahashi Kazuhisa

Primary Institution: Juntendo University

Hypothesis

Can dupilumab effectively treat eosinophilic gastritis in patients with severe asthma?

Conclusion

Dupilumab may be an effective treatment option for eosinophilic gastritis and severe asthma.

Supporting Evidence

  • The patient's eosinophilic gastritis symptoms improved after starting dupilumab.
  • Dupilumab also improved the patient's asthma symptoms and control.
  • No adverse events were reported following the treatment.

Takeaway

A woman with stomach pain and asthma got better after taking a medicine called dupilumab, which helped both her conditions.

Methodology

Case report detailing the treatment of a patient with eosinophilic gastritis and severe asthma using dupilumab.

Limitations

This study reports only one case, and biopsies were not performed on other parts of the gastrointestinal tract.

Participant Demographics

A 35-year-old woman with a history of asthma.

Digital Object Identifier (DOI)

10.1186/s13223-024-00940-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication